Academic Partnerships
Accelerating concepts into development with leading research centers and institutes
// Partnering
What We Do
We leverage our ecosystem of platform technologies and manufacturing capabilities to drive innovation. Partnering with us provides flexibility to your process, support with our infrastructure, and access to our expert scientific team.
Our Partnership Spotlights
Extending Our Manufacturing Footprint to Accelerate Cell and Gene Therapies
ElevateBio partnered with the University of Pittsburgh to locate a new BaseCamp process development and Good Manufacturing Practice (GMP) manufacturing facility in Pittsburgh. The facility will be fully equipped with cell and gene therapy-enabling technologies, including gene editing, induced pluripotent stem cell (iPSC) and cell, vector, and protein engineering capabilities.
Translating Research into Life-Changing Therapies
ElevateBio and Boston Children’s Hospital entered into a five-year collaborative agreement to advance cell and gene therapy programs originating out of Boston Children’s. The collaboration enables ElevateBio and Boston Children’s to form multiple cell and gene therapy companies together while providing researchers access to our enabling technologies, manufacturing capabilities and leading expertise.
Manufacturing Cell & Gene Therapies with Research Institutes
ElevateBio and Massachusetts General Hospital (MGH) formed a 10-year alliance agreement to provide MGH with preferred access to our BaseCamp process development and manufacturing facility in Waltham, MA for development and production of cell and gene therapies developed at MGH.
Developing iPSC-Derived Allogenic Immune Therapies
In collaboration with George Daley, M.D, Ph.D. and Boston Children’s Hospital, ElevateBio established a new company to develop off-the-shelf immune therapies derived from induced pluripotent stem cells (iPSCs). The company is founded upon a novel differentiation process that develops iPSCs into mature immune cells, which was detailed in a peer-reviewed publication in Cell Stem Cell.
This NewCo is enabled by our iPSC and gene editing technologies and scale-up manufacturing capabilities to develop a broad pipeline of iPSC-derived therapies.
Partner Testimonials
We have some exceptional emerging research coming out of the University of Pittsburgh. However, the missing ingredient has been access to high-quality process science and manufacturing capabilities. As we position ourselves to become the next global hub for life sciences and biotech, we were in search of the right partner to help us realize our vision, and ElevateBio’s expertise and reputation in cell and gene therapy made them the perfect partner to accelerate our ability to build our biomanufacturing center of excellence.
The management team, the technology platforms and the manufacturing capabilities convinced me to work with ElevateBio.
Partner With Us
Wherever you are in your product lifecycle, we can strengthen and accelerate the development of your transformative therapies with our enabling technologies unmatched manufacturing capabilities.
// Work with us
